argenx · 1 day ago
Senior Manager, US HCP Marketing
Boston, MA
Full-time
Hybrid
Mid, Senior Level
3+ years expargenx is a biotech company transforming immunology and delivering medicines for autoimmune patients. The Senior Manager, US HCP Marketing will develop and execute marketing strategies and tactics directed at healthcare professionals to promote VYVGART in specific indications, collaborating closely with cross-functional partners.
BiotechnologyClinical TrialsTherapeutics
Responsibilities
Support the development and execution of the disease state strategy, messaging, and tactics to ensure optimized Market Development prior and after launch
Support the development and execution of the Branded efgartigimod strategy, messaging and tactics for an indication launch in the US
Gain Market Insights to refine launch strategies to support the efgartigimod indications. This includes planning and execution of commercial ad boards, aligning with cross functional partners on strategic intent of ad boards, identifying appropriate advisors, developing stimuli and workshop design, and sharing of insights with broader organization to inform decision-making across multiple functions
Support the development, execution and US implementation of core peer-to-peer initiatives and materials for HCPs. This includes the establishment of our disease state and branded speaker's bureau, the initial identification and training of speakers, and other non-personal channels for achieving P2P influence
Support ongoing development and pull-through of the efgartigimod indication specific strategy. Ensure customer and competitor insights drive updates to strategy
Align with Sales leadership on ensuring readiness of materials to support the Commercial Field Organization and work cross-functionally to prepare materials to support the Field Organization for Launch
Manage multiple agency partners, including management of associated budgets, forecasts / accruals. Manage project timelines, including development of work plans and routing of all promotional materials through the appropriate review channels
Support the VYVGART brand strategies with pull-through to national congress channel and regional congress execution. Manage Congress participation, including cross functional congress planning, booth design, and execution of commercial tactics, sponsorships, and events
Collaborate with multiple functional groups within the organization, including but not limited to Marketing, Digital Marketing, Marketing Operations, Field Sales, Medical Affairs, Market Access, Compliance, Legal and Regulatory
Partner with non-personal promotional (NPP) lead to align strategy and tactics, as well as to optimize data analytics and inform business decisions
Work closely with Legal, Regulatory and Medical Affairs to effectively navigate Promotional Material Review process, prioritize and ensure timely and compliant development of HCP-directed tactics
Execute multiple, simultaneous projects and manage resources to ensure deliverables are on time, on budget, and address business objectives
Qualification
Required
BS/BA degree (science or business degree preferred); MBA is a plus
3 years of experience in marketing and/or relevant commercial experience in the pharmaceutical/biotech industry
Experience effectively managing external agency partners, and collaborating with cross-functional teams and internal/external stakeholders to effectively implement strategies and programs
Understanding of the legal and regulatory environment in pharmaceutical promotions
Strong project management, communication, and organization skills
Agility, proven ability to influence without authority and cross-functional collaboration
Ability to work under pressure in a fast-paced environment and prioritize work to achieve positive results
Travel 30%
Preferred
Experience in rare disease and/or neurology
US launch readiness experience
Benefits
Short-term and long-term incentive programs
Comprehensive benefits package
Retirement savings plans
Health benefits
Company
argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$3.75BKey Investors
Forbion Capital Partners
2023-07-18Post Ipo Equity· $1.1B
2022-03-23Post Ipo Equity· $700M
2021-02-02Post Ipo Equity· $999.38M
Leadership Team
Karen Massey
Chief Operating Officer
Carine Rivet-Thions
Associate Director Regulatory Affairs Labeling
Recent News
belganewsagency.eu
2026-01-16
2026-01-16
Company data provided by crunchbase